Home › Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher
 

Keywords :   


Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher

2014-10-25 17:46:08| Biotech - Topix.net

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Tags: higher charge leading jim

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Tropical Storm Beryl Public Advisory Number 40A
08.07Swine industry responds to H5N1 outbreak in dairy cattle
08.07Simply.TV acquires InFlow Media
08.07Atlantic Tropical Weather Outlook
08.07Planetcast announces faultless delivery of 2024 IPL season
08.07Eastern North Pacific Tropical Weather Outlook
08.07Tropical Storm Beryl Storm Surge Watch/Warning Map
08.07TelevisaUnivision selects Skyline for IP-based distribution system monitoring
More »